Eli Lilly’s Mounjaro Poised to Disrupt Diabetes, Obesity Markets
Will Eli Lilly’s Mounjaro disrupt the diabetes and weight loss treatment markets? How much share will the drug secure?
Report Date :
01/19/2023
Topic :
Eli Lilly and Co.
Source Silos :
1) Diabetes and weight loss medical professionals
2) Diabetes and weight loss treatment sales professionals
3) Third-party payers
4) Industry specialists
5) Secondary sources
Sector :
Health Care
Companies :
AZN, LLY, NVO, PRVB, SNY
Industry :
Health Care Equipment & Supplies
Eli Lilly’s Mounjaro Poised to Disrupt Diabetes, Obesity Markets PDF